248 related articles for article (PubMed ID: 17083031)
1. Cotrimoxazole prophylaxis in HIV-infected pregnant women: only a first step.
Heather Watts D; Mofenson LM
J Infect Dis; 2006 Dec; 194(11):1478-80. PubMed ID: 17083031
[No Abstract] [Full Text] [Related]
2. Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts.
Walter J; Mwiya M; Scott N; Kasonde P; Sinkala M; Kankasa C; Kauchali S; Aldrovandi GM; Thea DM; Kuhn L
J Infect Dis; 2006 Dec; 194(11):1510-8. PubMed ID: 17083035
[TBL] [Abstract][Full Text] [Related]
3. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
Le Moal G; Breux JP; Roblot F
N Engl J Med; 2001 May; 344(21):1639-41. PubMed ID: 11374363
[No Abstract] [Full Text] [Related]
4. Cotrimoxazole prophylaxis for infants exposed to HIV infection.
Graham SM
Bull World Health Organ; 2004 Apr; 82(4):297-8. PubMed ID: 15259259
[No Abstract] [Full Text] [Related]
5. The obstetric face and challenge of HIV/AIDS.
Guidozzi F; Black V
Clin Obstet Gynecol; 2009 Jun; 52(2):270-84. PubMed ID: 19407534
[TBL] [Abstract][Full Text] [Related]
6. Cotrimoxazole prophylaxis in HIV-infected individuals after completing anti-tuberculosis treatment in Thyolo, Malawi.
Zachariah R; Spielmann MP; Harries AD; Gomani P; Bakali E
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1046-50. PubMed ID: 12546111
[TBL] [Abstract][Full Text] [Related]
7. Managing Q fever during pregnancy: the benefits of long-term cotrimoxazole therapy.
Carcopino X; Raoult D; Bretelle F; Boubli L; Stein A
Clin Infect Dis; 2007 Sep; 45(5):548-55. PubMed ID: 17682987
[TBL] [Abstract][Full Text] [Related]
8. Use of cotrimoxazole prophylaxis in HIV infected in patients at a referral hospital.
Khoza S; Mkudu V; Mthethwa J; Bulaya-Tembo R; Nhachi CF
Cent Afr J Med; 2010; 56(5-8):26-30. PubMed ID: 23457847
[TBL] [Abstract][Full Text] [Related]
9. Response to Kourtis et al. 'Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis'.
Townsend CL; Cortina-Borja M; Peckham CS; Tookey PA
AIDS; 2007 Aug; 21(13):1831-2. PubMed ID: 17690590
[No Abstract] [Full Text] [Related]
10. Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection.
Gill CJ; Sabin LL; Tham J; Hamer DH
Bull World Health Organ; 2004 Apr; 82(4):290-7. PubMed ID: 15259258
[TBL] [Abstract][Full Text] [Related]
11. Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy.
Haeri S; Shauer M; Dale M; Leslie J; Baker AM; Saddlemire S; Boggess K
Am J Obstet Gynecol; 2009 Sep; 201(3):315.e1-5. PubMed ID: 19733286
[TBL] [Abstract][Full Text] [Related]
12. Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003.
Martí C; Peña JM; Bates I; Madero R; de José I; Pallardo LF; Arribas JR; Gonzalez-Garcia J; Gonzalez A; Vazquez JJ
Acta Obstet Gynecol Scand; 2007; 86(4):409-15. PubMed ID: 17486461
[TBL] [Abstract][Full Text] [Related]
13. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
[TBL] [Abstract][Full Text] [Related]
14. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.
Warszawski J; Tubiana R; Le Chenadec J; Blanche S; Teglas JP; Dollfus C; Faye A; Burgard M; Rouzioux C; Mandelbrot L;
AIDS; 2008 Jan; 22(2):289-99. PubMed ID: 18097232
[TBL] [Abstract][Full Text] [Related]
15. Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis.
Kourtis AP; Schmid CH; Jamieson DJ; Lau J
AIDS; 2007 Mar; 21(5):607-15. PubMed ID: 17314523
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
[TBL] [Abstract][Full Text] [Related]
17. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
Bender MA; Sax PE
N Engl J Med; 2001 May; 344(21):1639; author reply 1640-1. PubMed ID: 11374364
[No Abstract] [Full Text] [Related]
18. Recommendations for fungal opportunistic infections prevention in persons infected with human immunodeficiency virus.
Popa LG; Popa MI; Zaharia A; Ocneanu M
Roum Arch Microbiol Immunol; 1999; 58(2):185-95. PubMed ID: 11845456
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy complications and birth outcomes of pregnant women with urinary tract infections and related drug treatments.
Bánhidy F; Acs N; Puhó EH; Czeizel AE
Scand J Infect Dis; 2007; 39(5):390-7. PubMed ID: 17464860
[TBL] [Abstract][Full Text] [Related]
20. Co-trimoxazole prophylaxis in tropical countries in the era of highly active antiretroviral therapy: do we know enough?
Lynen L; Jacobs J; Colebunders R
Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1059-60. PubMed ID: 17662321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
